In partnership with the MHA Keystone Center, Michigan Opioid Partnership and the Michigan Department of Health and Human Services, the Community Foundation for Southeast Michigan (CFSEM) is launching a new Emergency Department Medication for Opioid Use Disorder Initiative and funding opportunity for Michigan hospitals. The initiative aims to increase access to evidence-based medication for opioid use disorder (MOUD) and support the transition to long-term, office-based treatment upon discharge. More information about the initiative is available in an online video.
The first application cycle will open Nov. 8 and close Nov. 29. There will be at least two additional application cycles during the award period, which ends Sept. 30, 2022, and will depend upon remaining funding. Grant funds are limited and are available on a first-come, first-served basis.
Eligibility will be determined by the number of patients each hospital treats annually for opioid-related overdoses (i.e., encounters). Eligible hospitals are encouraged to coordinate and apply as a system. If two or more eligible hospitals from the same system are interested in applying, they are encouraged to contact the CFSEM to discuss the possibility of applying as a system. Eligibility for grant funding is outlined as follows:
- Hospitals with more than 100 encounters annually are eligible for technical assistance and up to $150,000.
- Hospitals with 50-100 encounters annually are eligible for technical assistance and up to $75,000.
- Hospitals with less than 50 encounters annually are eligible for technical assistance and are strongly encouraged to contact the CFSEM if interested. Currently, hospitals with fewer than 50 encounters annually are ineligible for funding.
Application instructions and grant guidelines are available on the CFSEM website, and future application cycles will be posted there. Members may contact the MHA Keystone Center with questions and email CFSEM to learn more or to request a meeting to discuss this opportunity.